Bio-Techne
-
Ticker
TECH
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1001-5000 Employees
- Based in Minneapolis, Minnesota
Techne Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls worldwide. It operates in two segments, Biotechnology and Clinical Controls. The Biotechnology segment provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits used by researchers
…More to quantify the level of a specific protein in biological fluids, such as serum, plasma, or urine; and clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and Beta2-microglobulin immunoassays for use as in vitro diagnostic devices.
REPORT RATINGS
4.7 / 5.0 (106)
Bio-Techne reports have an aggregate usefulness score of 4.7 based on 106 reviews.
Bio-Techne
Most Recent Responsibility Report
MOST RECENT
2023 Corporate Sustainability Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Bio-Techne Sustainability Report, Bio-Techne Corporate Social Responsibility Report, Bio-Techne CSR Report, Bio-Techne Corporate Responsibility, Bio-Techne CR Report, Bio-Techne Citizenship Report, Bio-Techne ESG Report, and Bio-Techne Environmental Report online.